MedTrace Logo

Bioelectric Impedance in Non-invasive Ventilated Patients: The NIVAR Study.

NCT06996197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2025-06-04

No results posted yet for this study

Summary

Investigators performed a retrospective observational single-centre study in a cohort of COVID-19 patients with AHRF who required NIV support and intensive care unit (ICU) admission from May 2021 to January 2022. A BIA assessment was performed within the first 24 hours after NIV onset. Patient characteristics, severity scores, HACOR score, NIV settings, and mortality were recorded. Cox-hazard multivariate analysis was used to assess the association between BIA parameters and NIV failure, adjusting for potential covariates.

Conditions

  • Hypoxemic Acute Respiratory Failure
  • Non Invasive Ventilation (NIV)
  • Bioimpedance Measurement Capacity

Interventions

OTHER

Bioimpedance analysis

BIA parameters were measured within the first 24h of ICU admission, once the patient was receiving NIV support.

Sponsors & Collaborators

  • Hospital Universitari de Bellvitge - IDIBELL

    collaborator UNKNOWN

  • University of Barcelona

    collaborator OTHER

  • Hospital Clinic de Barcelona, Barcelona, Spain

    collaborator UNKNOWN

  • Institute of Sport Science and Sport

    collaborator UNKNOWN

  • CIBER of Respiratory Diseases CIBERES, Madrid

    collaborator UNKNOWN

  • Hospital Universitari de Bellvitge

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-12
Primary Completion
2022-01-14
Completion
2022-01-14

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06996197 on ClinicalTrials.gov